Westside Investment Management, Inc. - TITAN PHARMACEUTICALS INC DE ownership

TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 47 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Westside Investment Management, Inc. ownership history of TITAN PHARMACEUTICALS INC DE
ValueSharesWeighting
Q4 2018$522,000
+6.3%
2,3430.0%0.00%
Q3 2018$491,000
-84.0%
2,343
-18.9%
0.00%
-100.0%
Q2 2018$3,063,000
+6.0%
2,8890.0%0.00%
-50.0%
Q1 2018$2,889,000
-28.5%
2,8890.0%0.00%0.0%
Q4 2017$4,040,000
-41.7%
2,8890.0%0.00%
-50.0%
Q3 2017$6,929,000
+18.5%
2,889
-8.6%
0.00%0.0%
Q2 2017$5,849,000
-36.1%
3,162
+10.5%
0.00%0.0%
Q1 2017$9,159,000
+18.7%
2,862
+57.6%
0.00%
-20.0%
Q4 2016$7,718,0001,8160.01%
Other shareholders
TITAN PHARMACEUTICALS INC DE shareholders Q2 2017
NameSharesValueWeighting ↓
THOMPSON DAVIS & CO., INC. 16,184$95,0000.17%
Acrospire Investment Management LLC 30,847$181,0000.12%
Spark Investment Management LLC 24,000$141,0000.01%
ACCURATE INVESTMENT SOLUTIONS, INC. 2,000$12,0000.01%
Blume Capital Management, Inc. 2,546$15,0000.01%
BLUESTEIN R H & CO LLC 20,000$118,0000.01%
Virtu KCG Holdings LLC 42,562$250,0000.01%
ARCADIA INVESTMENT MANAGEMENT CORP/MI 1,819$11,0000.00%
Integrated Wealth Management 910$5,0000.00%
Krilogy Financial LLC 800$5,0000.00%
View complete list of TITAN PHARMACEUTICALS INC DE shareholders